Across the EU, cannabinoid extracts including cannabinol are classified as unauthorised novel foods under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state.
Finland's food position covers cannabinoids as a class, not cannabidiol alone, so cannabinol has no lawful route as a food or food supplement.
The notable Finnish fact is what cannabinol is not. It is named nowhere in the government decree on substances regarded as narcotics, in any of its annexes and through every amendment to date. It is named nowhere in the decree on psychoactive substances banned from the consumer market, including the consolidation in force from 10 July 2026. And it is not in Annex 1 of Fimea's medicines list 230/2025, where cannabidiol is. Cannabinol is therefore the one tracked cannabinoid that Finland has not brought within any control instrument.
That is a real asymmetry, but it is not a permission. Fimea's medicines list states in its own terms that it is not exhaustive, so a cannabinol product can be classified a medicine case by case without any list entry. Finland has also been amending its psychoactive-substances annex aggressively in this substance family, adding a hydrogenated cannabidiol derivative with effect from 10 July 2026.